Daqin Suo
Impact in
-
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Medicinal Plants and Neuroprotection
Papers in
-
- RNA modifications and cancer 2
- Metabolism, Diabetes, and Cancer 1
- Oncology 5
- Pancreatic and Hepatic Oncology Research 2
- Peptidase Inhibition and Analysis 1
- Co-authors
- Xin‐Yuan Guan (9 shared papers)Lichao Yang (3 shared papers)Wushuang Yang (3 shared papers)Yun Zhao (3 shared papers)Xin Jin (3 shared papers)Yan Li (7 shared papers)Yudong Zhou (2 shared papers)Tingting Zeng (6 shared papers)
In The Last Decade
Daqin Suo
13 papers receiving 292 citations
Peers
Comparison fields: 5 of 60
- Neurology 59
- Complementary and alternative medicine 36
- Cancer Research 64
- Pharmacology 43
- Developmental Neuroscience 9
Countries citing papers authored by Daqin Suo
This map shows the geographic impact of Daqin Suo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daqin Suo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daqin Suo more than expected).
Fields of papers citing papers by Daqin Suo
This network shows the impact of papers produced by Daqin Suo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daqin Suo. The network helps show where Daqin Suo may publish in the future.
Co-authors
The 25 scholars most cited alongside Daqin Suo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 50 | |
| 2 | 2018 | 43 | |
| 3 | 2020 | 37 | |
| 4 | 2014 | 32 | |
| 5 | 2017 | 31 | |
| 6 | 2020 | 30 | |
| 7 | 2022 | 27 | |
| 8 | 2020 | 15 | |
| 9 | 2024 | 10 | |
| 10 | 2023 | 7 | |
| 11 | 2020 | 7 | |
| 12 | 2021 | 5 | |
| 13 | 2024 | 2 | |
| 14 | 2025 | 0 |
About Daqin Suo
Daqin Suo is a scholar working on Molecular Biology, Oncology, Immunology, Neurology and Complementary and alternative medicine, having authored 14 papers that have together received 296 indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Anesthesia and Neurotoxicity Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Medicinal Plants and Neuroprotection (2 papers), RNA modifications and cancer (2 papers), Peptidase Inhibition and Analysis (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Neurology (59 citations), Complementary and alternative medicine (36 citations), Cancer Research (64 citations), Pharmacology (43 citations) and Developmental Neuroscience (9 citations). Daqin Suo has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Xin‐Yuan Guan, Lichao Yang, Wushuang Yang, Yun Zhao, Xin Jin, Yan Li, Yudong Zhou, Tingting Zeng, Lei Li and Tong Ren. Their work appears in journals such as Oncogenesis, Cancer Research, Cell Death Discovery, Brain Behavior and Immunity and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.